WO2020262157A1 - 皮膚洗浄用スプレー剤 - Google Patents

皮膚洗浄用スプレー剤 Download PDF

Info

Publication number
WO2020262157A1
WO2020262157A1 PCT/JP2020/023784 JP2020023784W WO2020262157A1 WO 2020262157 A1 WO2020262157 A1 WO 2020262157A1 JP 2020023784 W JP2020023784 W JP 2020023784W WO 2020262157 A1 WO2020262157 A1 WO 2020262157A1
Authority
WO
WIPO (PCT)
Prior art keywords
skin
spray
acid
cleansing
skin cleansing
Prior art date
Application number
PCT/JP2020/023784
Other languages
English (en)
French (fr)
Japanese (ja)
Inventor
航平 山本
Original Assignee
小林製薬株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 小林製薬株式会社 filed Critical 小林製薬株式会社
Priority to CN202080003388.4A priority Critical patent/CN112367965A/zh
Publication of WO2020262157A1 publication Critical patent/WO2020262157A1/ja

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/046Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations

Definitions

  • the present invention relates to a skin cleansing spray agent used by directly spraying it on the skin.
  • Various skin cleansing compositions such as facial cleansers, body soaps, and shampoos are provided as products aimed at cleaning the skin and keeping the skin clean.
  • the surfactant adsorbs to the dirt to reduce the surface tension between the dirt and water, and the mechanical force due to friction causes the dirt to float in the water.
  • it is necessary to add a surfactant at a critical micelle concentration or higher.
  • Patent Document 1 describes a liquid skin cleaning agent product comprising a former container and a liquid skin cleaning agent composition filled in the former container, wherein the liquid skin cleaning agent composition is (1).
  • Liquid skin containing the copolymer of (C) and (C) sugar alcohol, and the mass ratio (A) / (B) of the content of the component (A) to the content of the component (B) is 20 to 250.
  • Cleaning agent products are disclosed.
  • Patent Document 2 states that (a) fatty acid salt is 2 to 9% by mass, (b) betaine lauryldimethylaminoacetate is 0.5 to 4% by mass, and (c) one or more dihydric alcohols.
  • a skin cleaning agent composition which comprises filling a former container with a cleaning agent having a / (a) of 0.1 to 0.5.
  • Patent Document 3 describes a former container containing (a) betaine lauryldimethylaminoacetate and (b) 4 to 15% by mass of a higher fatty acid soap having a specific composition and formed from a fatty acid having 5 to 25 carbon atoms. The cleaning agent composition discharged in the above is disclosed.
  • Patent Document 4 describes 11 to 45 parts by weight of a natural surfactant, 25 to 35 parts by weight of mirabyl stone, 10 to 40 parts by weight of a hard water softener, 0.1 to 5 parts by weight of a chelating agent, and an additional residue.
  • a cleaning agent composition is disclosed in which the total amount of the various cleaning agent raw materials is 100 parts by weight.
  • the pumpformer-type skin cleansing composition contains a relatively small amount of surfactant, and in that respect, irritation to the skin is reduced as compared with the solid or semi-solid skin cleansing composition. It is thought that there is a tendency to be. On the other hand, since it is a major premise that the pump former type skin cleansing composition is discharged in the form of foam, the minimum amount of surfactant necessary for exerting the foaming force is blended. That is inevitable due to its composition.
  • various skin cleaning agents have been created for the purpose of removing body fluids such as sebum and sweat and dirt, excluding skin cleaning agents for the purpose of removing makeup (cleansing), but pump former type skin cleaning agents.
  • charges and natural surfactants which skin cleanser including skin cleanser containing also without exception, based on the premise that the whipping before applying to the skin, also bubbling well before cleaning, relieve friction on the skin
  • Foam can relieve physical friction by intervening between the skin and the hand, but since the foam itself is rubbed against the skin, it itself causes physical friction and is irritating to the skin. There is no change in being. As described above, there is a limit to the reduction of the burden on the skin of the skin cleansing agent by the same usage method as before.
  • an object of the present invention is to provide a skin cleansing composition used by a method different from the conventional method.
  • the present inventor has come up with the idea of a novel application in which the skin cleansing composition is directly sprayed onto the skin without foaming in advance when applied to the skin in order to further reduce irritation to the skin. ..
  • a naturally-derived surfactant was blended, and the blending amount thereof was significantly reduced as compared with the blending amount contained in the conventional skin cleansing composition.
  • a skin cleansing composition containing such a significantly small amount of surfactant does not provide cleansing power in exchange for reduced irritation to the skin, but by coexisting with an amphipathic ester, it does not foam in advance.
  • the present invention has been completed by further studies based on this finding.
  • Item 1 For skin cleansing, which contains (A) a naturally occurring surfactant and (B) an amphipathic ester, and has a content of (A) of 0.025 to 2% by weight and is contained in a spray container.
  • Spray agent Item 2.
  • Item 2. The spray agent for skin cleaning according to Item 1, wherein the spray container is a pump type spray container.
  • Item 2. The spray agent for skin cleaning according to Item 1, wherein the spray container is an aerosol spray container.
  • Item 4. Item 2. The skin cleansing spray agent according to any one of Items 1 to 3, wherein the component (A) is selected from the group consisting of glycerophospholipids, saponins, and lipopeptides.
  • Item 5 The skin cleansing spray agent according to Item 4, wherein the glycerophospholipid is selected from the group consisting of lecithin, lysolecithin, and hydrogenated lecithin.
  • Item 6. The skin cleansing spray agent according to Item 4, wherein the lipopeptide is selected from the group consisting of surfactins and salts thereof.
  • Item 7. Items 1 to 6 in which the component (B) is selected from the group consisting of a dicarboxylic acid bis (polyoxyalkylene alkyl ether) ester, a dicarboxylic acid dialkoxyalkyl ester, and a (icosane diic acid / tetradecane diic acid) polyglyceryl-10.
  • Item 7 The skin cleaning spray agent according to any one of.
  • Item 7 wherein the dicarboxylic acid bis (polyoxyalkylene alkyl ether) ester is cyclohexane-1,4-dicarboxylic acid bisethoxydiglycol.
  • the skin cleansing composition can exhibit excellent cleansing power while reducing the skin irritation, it is different from the conventional use of foaming in advance when applied to the skin, and directly on the skin. It is possible to provide a new application of spraying and applying a cleansing composition onto the skin. Since it can be washed without foaming in advance, the blending amount of the surfactant in the skin cleansing liquid composition can be significantly reduced as compared with the blending amount contained in the conventional skin cleansing liquid composition. It is also possible to further reduce skin irritation.
  • the skin cleansing spray agent of the present invention contains (A) a naturally occurring surfactant (hereinafter, may be referred to as (A) component) in a predetermined amount and (B) an amphipathic ester (hereinafter, (B) component). It is characterized in that it contains (sometimes referred to as) and is housed in a spray-type container.
  • A naturally occurring surfactant
  • B amphipathic ester
  • the skin cleansing spray agent of the present invention contains a naturally derived surfactant as the component (A).
  • Naturally-derived surfactants are substances that originate from living organisms and have a surfactant action.
  • the naturally occurring surfactant used in the present invention is not particularly limited, and is a natural product extracted and purified from animals, plants or microorganisms; these natural products are microbiologically cultured and synthesized, and genetically engineered. Products and chemically synthesized products; those subjected to treatments such as hydrogenation treatment, hydroxylation treatment, and hydrolysis treatment can be mentioned.
  • Examples of the naturally occurring surfactant used in the present invention include phospholipids, saponins, lipopeptides, cholesterol, bile acids and the like.
  • One of these naturally-derived surfactants may be used alone, or two or more thereof may be used in combination.
  • phospholipids, saponins and lipopeptides are preferable.
  • Examples of phospholipids include glycerophospholipids and sphingolipids.
  • Glycerophospholipid is a substance having a glycerophosphate skeleton, and has a fatty acid ester, a long-chain alkyl ether, a vinyl ether and the like as a parent oil group.
  • Specific examples of glycerophospholipids include phosphatidylcholine (lecithin), phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, phosphatidylinositol polyphosphate, diphosphatidylglycerol (cardiolipin), phosphatidylic acid, and hydrolyzed products and hydroxylation treatments thereof.
  • Sphingolipids are phosphoric acid or phosphonic acid derivatives of long-chain bases or long-chain fatty acids such as sphingosine and phytosphingosine.
  • Specific examples of sphingolipids include ceramide 1 phosphoric acid derivatives (sphingomyelin and the like) and ceramide 1-phosphonic acid derivatives (ceramide aminoethyl phosphonic acid and the like).
  • One of these phospholipids may be used alone, or two or more thereof may be used in combination.
  • glycerophospholipids are preferable, lecithin (soy lecithin, egg yolk lecithin), hydrogenated lecithin, hydroxylated lecithin, and lysolecithin are more preferable, and lecithin (soy lecithin, soybean lecithin,) is more preferable.
  • lecithin soybean lecithin
  • Egg yolk lecithin etc. hydrogenated lecithin, lysolecithin and the like.
  • lecithin seybean lecithin, egg yolk lecithin, etc.
  • lysolecithin are preferably mentioned from the viewpoint of obtaining more excellent detergency
  • hydrogenated lecithin is preferable from the viewpoint of further suppressing skin irritation and tension due to insufficient moisturization. Can be mentioned.
  • Saponin is a glycoside composed of sapogenin and sugar, and specific examples thereof include triterpene glycosides and steroid glycosides. Specific examples of the saponin include Kiraya saponin, soybean saponin, yukka saponin, enju saponin, beet saponin, azukisaponin, carrot saponin, tea species saponin, hechimasaponin, and tsubokusaponin. One of these saponins may be used alone, or two or more of them may be used in combination.
  • the lipopeptide is a lipidized peptide, and specific examples thereof include surfactin, arslovactin, itulin, and salts thereof.
  • One of these lipopeptides may be used alone, or two or more thereof may be used in combination.
  • surfactin and a salt thereof are preferably mentioned, and more preferably a salt of surfactin is mentioned.
  • the salt of surfactin is a compound represented by the following formula (I).
  • X represents an amino acid residue selected from leucine, isoleucine and valine
  • R represents a C 9-18 alkyl group
  • M + represents an alkali metal ion or a quaternary ammonium ion.
  • the alkali metal ion is not particularly limited, and examples thereof include lithium ion, sodium ion, potassium ion and the like, and sodium ion is preferable.
  • Examples of the substituent of the quaternary ammonium ion include an alkyl group such as a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group and a tert-butyl group; a benzyl group, a methylbenzyl group and a phenylethyl group.
  • Aralkyl groups such as groups; organic groups such as aryl groups such as phenyl group, toluyl group and xsilyl group can be mentioned.
  • One of these surfactins or a salt thereof may be used alone, or two or more thereof may be used in combination.
  • the content of component (A) in the skin cleansing spray agent of the present invention is 0.025 to 2% by weight. Since the amount of the surfactant is small as described above, the skin irritation can be significantly reduced. In the present invention, since excellent detergency can be exhibited by coexisting with the component (B), even a small amount of surfactant that cannot originally exhibit effective detergency can be exhibited. Detergency can be effectively exerted.
  • the preferable content of the component (A) is, for example, 0.5 to 2% by weight, more preferably 1 to 2% by weight from the viewpoint of obtaining even more excellent detergency, and gives a feeling of tension due to insufficient moisturizing. From the viewpoint of further suppression, 0.025 to 1.5% by weight, more preferably 0.025 to 1% by weight can be mentioned. Further, when the component (A) is lecithin or lysolecithin, 0.5 to 2% by weight is mentioned from the viewpoint of obtaining even more excellent detergency, and from the viewpoint of further suppressing the feeling of tension due to insufficient moisturizing, 0. 025 to 1% by weight, and 0.025 to 1.5% by weight from the viewpoint of further suppressing skin irritation. When the component (A) is saponin, 1 to 2% by weight can be mentioned from the viewpoint of obtaining even more excellent detergency.
  • the skin cleansing spray agent of the present invention contains an amphipathic ester as a component (B).
  • the component (B) does not show a cleansing effect by itself, but by coexisting with the component (A) of 0.025 to 2% by weight, the cleansing power of the skin cleansing spray agent is improved while maintaining low irritation. be able to.
  • the amphipathic ester is dissolved in ion-exchanged water adjusted to a conductivity of 70 to 110 ⁇ s / m in an amount of 2% by mass or more at room temperature by the method specified in the General Test Method of the Japanese Pharmacopoeia. , Isotridecyl isononanoate (manufactured by Nisshin Oillio Group, Saracos 913), which is an oil agent, also dissolves in 10% by mass or more at room temperature (25 ° C.), and ester-based surfactants are excluded.
  • the amphoteric ester is not particularly limited, but from the viewpoint of obtaining better skin irritation reduction property and detergency, a dicarboxylic acid bis (polyoxyalkylene alkyl ether) ester, a dicarboxylic acid dialkoxyalkyl ester, and (eicosandic acid) are used. / Tetradecanedioic acid) It is preferable that it is selected from the group consisting of polyglyceryl-10.
  • amphoteric ester any one of dicarboxylic acid bis (polyoxyalkylene alkyl ether) ester, dicarboxylic acid dialkoxyalkyl ester, and (eicosandioic acid / tetradecanedioic acid) polyglyceryl-10 is used alone. Also, two or more kinds may be used in combination. Among these amphipathic esters, the dicarboxylic acid bis (polyoxyalkylene alkyl ether) ester is more preferable from the viewpoint of further suppressing the feeling of tension due to insufficient moisturization.
  • the dicarboxylic acid bis (polyoxyalkylene alkyl ether) ester used in the present invention is a diester compound of a dicarboxylic acid and a polyoxyalkylene alkyl ether.
  • Specific examples of the dicarboxylic acid constituting the diester compound of the dicarboxylic acid bis (polyoxyalkylene alkyl ether) ester include oxalic acid, malonic acid, succinic acid, tartaric acid, malic acid, glutaric acid, adipic acid, pemeric acid, and the like.
  • Examples thereof include suberic acid, azelaic acid, sebacic acid, aspartic acid, glutamic acid, acetonedicarboxylic acid, phthalic acid, cyclohexane-1,4-dicarboxylic acid and the like.
  • Examples of the polyoxyalkylene alkyl ether constituting the diester compound include polyoxyethylene monoalkyl ether, and more specifically, diethylene glycol monoethyl ether and triethylene glycol monoethyl ether. Be done.
  • dicarboxylic acid bis (polyoxyalkylene alkyl ether) esters a diester of cyclohexane-1,4-dicarboxylic acid and diethylene glycol monoethyl ether is preferable from the viewpoint of obtaining better skin irritation reduction property and detergency.
  • cyclohexane-1,4-dicarboxylic acid bisethoxydiglycol examples include, for example, "Neosolue-Aqulio (trade name)” manufactured by Nippon Fine Chemical Co., Ltd.
  • specific examples of the bisethoxydiglycol succinate include "High Aquos Star DCS (trade name)” manufactured by Higher Alcohol Industry Co., Ltd.
  • dicarboxylic acid bis (polyoxyalkylene alkyl ether) esters may be used alone or in combination of two or more.
  • dicarboxylic acid bis (polyoxyalkylene alkyl ether) esters cyclohexane-from the viewpoint of further suppressing the feeling of tension due to insufficient moisturization, especially when hydrogenated lecithin or lipopeptide is used as the component (A). It is preferable to use bisethoxydiglycol 1,4-dicarboxylic acid.
  • the dicarboxylic acid dialkoxyalkyl ester used in the present invention is a diester compound of a dicarboxylic acid and an alkoxy alcohol.
  • Specific examples of the dicarboxylic acid constituting the diester compound of the dicarboxylic acid dialkoxyalkyl include oxalic acid, malonic acid, succinic acid, tartaric acid, malic acid, glutaric acid, adipic acid, pemeric acid, suberic acid, and azelaic acid. Examples thereof include sebacic acid, aspartic acid, glutamic acid, acetone dicarboxylic acid, phthalic acid, cyclohexane-1,4-dicarboxylic acid and the like.
  • Examples of the alkoxy alcohol constituting the diester compound include 2-methoxyethanol and 2-ethoxyethanol.
  • a diester compound of succinic acid and 2-ethoxyethanol is preferable, specifically, diethoxyethyl succinate, from the viewpoint of obtaining better skin irritation reduction property and detergency. Can be mentioned.
  • dicarboxylic acid dialkoxyalkyl esters may be used alone or in combination of two or more.
  • the polyglyceryl-10 (eicosanedioic acid / tetradecanedioic acid) used in the present invention is not particularly limited, but for example, "Neosolue-Aqua (trade name)" and “Neosolue-AquaS” manufactured by Nippon Seika Co., Ltd. Product name) ”and the like.
  • the content of the component (B) in the skin cleansing spray agent of the present invention is not particularly limited, and examples thereof include 0.1% by weight or more. From the viewpoint of obtaining better detergency and / or further reducing the feeling of tension due to insufficient moisturizing, the content of the component (B) is preferably 0.5% by weight or more, more preferably 1. 5% by weight or more, more preferably 2% by weight or more.
  • the upper limit of the content of the component (B) is not particularly limited, but from the viewpoint of the stability of the skin cleansing spray, for example, 5% by weight or less, preferably 4% by weight or less, more preferably 3% by weight or less. Can be mentioned.
  • the ratio of the component (A) to the component (B) is not particularly limited and is determined by each of the above-mentioned contents, but from the viewpoint of obtaining better skin irritation reduction property and cleansing power. Therefore, for example, the component (B) is 0.1 to 100 parts by weight, preferably 1 to 80 parts by weight with respect to 1 part by weight of the component (A). Further, from the viewpoint of obtaining even more excellent detergency, 1 to 4 parts by weight, more preferably 1 to 2 parts by weight of the component (B) is mentioned with respect to 1 part by weight of the component (A), and the tension due to insufficient moisturizing is mentioned.
  • the component (A) is lecithin or lysolecithin, from the viewpoint of obtaining even more excellent detergency, 1 to 4 parts by weight of the component (B) is mentioned with respect to 1 part by weight of the component (A) to moisturize. From the viewpoint of further suppressing the feeling of tension due to lack, 2 to 80 parts by weight of the component (B) is mentioned with respect to 1 part by weight of the component (A), and from the viewpoint of further suppressing the skin irritation, the component (A) 1 The component (B) is 1.2 to 80 parts by weight based on the weight part. When the component (A) is saponin, the component (B) is 1 to 2 parts by weight with respect to 1 part by weight of the component (A) from the viewpoint of obtaining even more excellent detergency.
  • the skin cleansing spray agent of the present invention contains other bases and additives required for formulation and the like as long as the effects of the present invention are not impaired. May be good.
  • Such additives are not particularly limited as long as they are pharmaceutically acceptable, but for example, water, lower alcohols having 1 to 5 carbon atoms (ethanol, isopropanol, etc.), and polyhydric alcohols (ethylene glycol, Aqueous bases such as 1,3-butylene glycol (BG), propylene glycol, isoprene glycol, diethylene glycol, dipropylene glycol, polypropylene glycol, glycerin, etc.; preservatives (phenoxyethanol, methylparaben, propylparaben, benzoic acid, sodium citrate) , Sorbonic acid, etc.), flavoring agents (citral, 1,8-cyonel, citroneral, farnesol, etc.), colorants (tar pigments (brown 201, blue 201, yellow 4, yellow 40
  • Viscous agent hydroxypropyl cellulose, hydroxyethyl cellulose, crosslinked acrylic acid polymer, carboxyvinyl polymer, hypromellose, polyvinylpyrrolidone, sodium alginate, ethyl cellulose, sodium carboxymethyl cellulose, xanthan gum, carrageenan, etc.
  • pH adjusters phosphate, hydrochloric acid, citrate, sodium citrate (trisodium citrate), succinic acid, tartrate, sodium hydroxide, potassium hydroxide, triethanolamine, triisopropanolamine, etc.
  • wetting agents dl- Sodium pyrrolidone carboxylate solution, D-sorbitol solution, macrogol, etc.
  • stabilizers dibutylhydroxytoluene, butylhydroxyanisole, sodium edetate, sodium metaphosphate, L-arginine, L-asparanic acid, DL-alanine, glycine ,
  • the skin cleansing spray agent of the present invention may contain, if necessary, other pharmacological components in addition to the above-mentioned components as long as the effects of the present invention are not impaired.
  • pharmacological components include vitamins (vitamin A, vitamin B1, vitamin B2, vitamin B5, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin K, niacin).
  • the form of the skin cleansing spray agent of the present invention is liquid or gel at room temperature.
  • the viscosity of the skin cleansing spray agent of the present invention is 10,000 mPa ⁇ s or less, preferably 5000 mPa ⁇ s or less at 20 ° C.
  • the viscosity is a value measured by a BL viscometer (rotor No. 3, 6 rpm, 20 ° C.).
  • the container for accommodating the skin cleansing spray agent of the present invention is not particularly limited as long as it is a spray type container.
  • the spray container in the present invention discharges the contents in a mist state, and is different from the pump former container that discharges the skin cleansing composition in a foam state.
  • the skin cleansing spray agent is directly applied to the skin by spraying without foaming before application to the skin. .. Therefore, it is easy to apply to the skin, and physical friction by hands or the like at the time of application can be avoided.
  • the spray type container include a pump type spray container which is a non-aerosol type spray container and an aerosol type spray container.
  • the diameter (nozzle inner diameter) of the spray container include 0.01 to 3 mm ⁇ , preferably 0.1 to 1 mm ⁇ .
  • the injection amount per push is, for example, 0.05 to 1.2 g, preferably 0.1 to 0.3 g.
  • the skin cleansing spray of the present invention is used to remove body fluids such as oils and sweats on the skin, stains, etc., and is not used as a makeup remover (cleansing).
  • the skin cleansing spray agent of the present invention is used by applying it to the skin as it is without foaming without diluting with water.
  • the amount used at one time depends on the concentration of the surfactant, the degree of stain, etc., but for example, when used for face washing, 0.5 to 3 g, preferably 1 to 2 g can be mentioned.
  • the spray agent for skin cleansing of the present invention is a formulation having excellent cleansing power, it is possible to cleanse the skin by using the mechanical force of the liquid flow without giving physical friction in this way. The burden is significantly reduced and an extremely gentle cleaning method becomes possible.
  • the skin cleansing spray agent of the present invention is particularly suitable for the above-mentioned cleaning method that does not give physical friction to the skin, but after applying the skin cleansing spray agent to the site to be cleaned, a hand or the like is used. It does not exclude the usage of scrubbing.
  • the site to be cleaned of the skin cleansing spray agent of the present invention is not particularly limited because it can clean any body part, and examples thereof include hands, hair, scalp, body, and face. Since the spray agent for skin cleaning of the present invention is applied to the site to be cleaned by spraying, it is suitable for use on hair, scalp, and body from the viewpoint of ease of application. In addition, the skin cleansing spray agent of the present invention can exert excellent cleansing power without foaming in advance, and is therefore suitable for use on the face sensitive to irritation.
  • the skin cleansing spray can be washed away with water.
  • it may be performed in the same manner as a normal face wash, but from the viewpoint of reducing the burden on the skin, it is preferable to wash off using the mechanical force of the water stream so as not to give friction by hand.
  • the skin cleansing spray agent of the present invention is also suitable for cleaning in hospitals, skin cleansing treatments such as face washing in beauty salons and beauty salons, and disaster supplies. If it is not washed away, a water-absorbent base material such as a towel or tissue may be used to absorb and remove the skin-cleaning spray agent remaining on the washed area.
  • the skin cleansing spray agent of the present invention is prepared into a predetermined form by mixing the above-mentioned components (A) and (B), and other components to be blended as necessary, and then prepared into a predetermined form.
  • Manufactured by being housed in a spray container.
  • a spray container When it is housed in an aerosol spray container as a spray container, it is manufactured by being housed together with a spray agent such as gas.
  • Tables 1 to 4 prepared skin cleansing sprays having the compositions shown in Tables 1 to 4. Details of each component shown in Tables 1 to 4 are as follows.
  • the skin cleansing sprays shown in Tables 1 to 4 are liquid, and their viscosities at 20 ° C. (measured by BL viscometer (Brookfield B-type viscometer) rotor No. 3 and 6 rpm) are all 5000 mPa. ⁇ It was in the range of s or less.
  • Lysolecithin Lysolecithin Kyowa (manufactured by Kyowa Hakko Bio)
  • Saponin Soap nut extract powder (made by Ichimaru Falcos) (saponin content 20% by weight)
  • Sodium surfactin Kaneka surfactin (made by Kaneka) -Cyclohexane-1,4-dicarboxylic acid bisethoxydiglycol ("Neosolue-Aqulio (trade name)” manufactured by Nippon Fine Chemical Co., Ltd.)
  • Bisethoxydiglycol succinate (“High Aquos Star DCS (trade name)” manufactured by Higher Alcohol Industry Co., Ltd.)
  • each skin cleansing spray agent is contained in a pump-type spray container (injection amount per push of "Z-155-C110 (trade name)" manufactured by Takemoto Yohki Co., Ltd. is 0.15 g). It was applied by spraying 5 g directly onto the face. It was left for about 5 seconds, and then rinsed with water so that the hands did not touch the face. After holding the face with a towel and absorbing water, the feeling of dirt removal on the skin was scored by sensory evaluation based on the following indexes.
  • each skin cleansing spray agent is contained in a pump-type spray container (Takemoto Yohki Co., Ltd. "Z-155-C110 (trade name)" (injection amount per push is 0.15 g), and 1 .5 g was applied by spraying directly on the face. Leave it for about 5 seconds, then rinse with water so that the hands do not touch the face. Hold the face with a towel and absorb the water, then feel taut. Was scored by sensory evaluation based on the following indexes. The stronger the degree of tension, the less moisturizing.
  • ⁇ Cultured epidermal skin irritation test (in vitro evaluation of skin irritation)> The prepared skin cleansing spray was subjected to a cultured epidermal skin irritation test as follows. 1. 1. Preparation of Cultured Epidermis Model LabCite EPI-MODEL24 The assay medium was warmed and 0.5 mL each was added to a 24-well assay plate. Cultured epidermis model LabCite EPI-MODEL24 (lot number: LCE24-180226-A) was transferred to a 24-well assay plate supplemented with assay medium. After confirming that there were no bubbles on the bottom surface of the culture cup, the cells were placed in a CO 2 incubator and allowed to stand for 1 hour or more until exposure to the test substance.
  • test substance Twelve of the 24 epidermis models were used (the rest were pre-cultured until this test). A 24-well assay plate was removed from the CO 2 incubator. The assay medium was warmed and 1.0 mL each was added to the third row of the 24-well assay plate. 25 ⁇ L of the test substance (spray agent for cleaning each skin) was added dropwise to the culture epidermis of the culture cup without using a pump-type spray container, and the whole was exposed. After 1 minute, 5 minutes and 10 minutes after exposure, the test substance was aspirated and removed, and the cultured epidermis model in the cup was washed with phosphate buffer (PBS) and transferred to the third row of the 24-well assay plate.
  • PBS phosphate buffer
  • MTT test occurs when MTT [3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyltrazolium bromide] taken up into cells is reduced by intracellular mitochondrial dehydrogenase. This is a method of measuring the viable cell ratio by extracting a formazan dye with an organic solvent and measuring the absorbance at 570 nm.
  • MTT medium 10 mL was prepared at a final concentration of 0.5 mg / mL.
  • the MTT medium was warmed and 0.5 mL each was added to row 4 of the 24-well assay plate.
  • the cultured epidermis model was transferred to row 4 of the 24-well assay plate and placed in a CO2 incubator for 3 hours MTT reaction. After completion of the MTT reaction, the cultured skin was picked up with tweezers and taken out, and transferred to a 1.5 mL microtube. 300 ⁇ L of isopropanol was placed in a microtube and the cultured epidermis model was completely immersed. After that, it was allowed to stand for 2 hours, and the microtube was vortexed to extract the pigment.
  • Extract 200 mL was placed in each well of a 96-well plate. Further, as a blank (negative control), 200 ⁇ L of isopropanol was added to A1. Absorbance at 570 nm and 650 nm was measured with a microplate reader. The value obtained by subtracting the absorbance at 650 nm from the absorbance at 570 nm was used as the measured value, and the viable cell ratio of the test substance was calculated from the following formula.
  • the viable cell rate was classified based on the following criteria, and skin irritation was evaluated. The results are shown in Tables 3-4. ⁇ : 90% or more ⁇ : 75% or more and less than 90% ⁇ : 65% or more and less than 75% ⁇ : 50% or more and less than 65% ⁇ ⁇ : less than 50%
  • the skin cleaning sprays (Comparative Examples 13 to 16) containing a surfactant in a concentration of more than 2% by weight were found to be skin irritating, and the naturally occurring surfactant was 0.025 to 0.025. No detergency was observed with the skin cleaning sprays (Comparative Examples 1 to 10) contained at a concentration of 2% by weight.
  • a skin cleansing spray containing 0.025 to 2% by weight of a naturally occurring surfactant containing an amphipathic ester (Comparative Examples 11 to 12) which does not show detergency by itself (Examples 1 to 21).
  • the skin cleansing spray agent of the present invention improves the cleansing power while suppressing the skin irritation and the feeling of tension due to insufficient moisturization. It was shown to be doing. In other words, by setting the concentration of the naturally occurring surfactant of the skin cleaning spray agent that is applied directly to the skin by spraying to 0.025 to 2% by weight, it is possible to perform cleaning that is physically and chemically gentle on the skin. Was shown.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
PCT/JP2020/023784 2019-06-26 2020-06-17 皮膚洗浄用スプレー剤 WO2020262157A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202080003388.4A CN112367965A (zh) 2019-06-26 2020-06-17 皮肤清洗用喷雾剂

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019-118265 2019-06-26
JP2019118265A JP2021004203A (ja) 2019-06-26 2019-06-26 皮膚洗浄用スプレー剤

Publications (1)

Publication Number Publication Date
WO2020262157A1 true WO2020262157A1 (ja) 2020-12-30

Family

ID=74061628

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2020/023784 WO2020262157A1 (ja) 2019-06-26 2020-06-17 皮膚洗浄用スプレー剤

Country Status (4)

Country Link
JP (1) JP2021004203A (zh)
CN (1) CN112367965A (zh)
TW (1) TW202114619A (zh)
WO (1) WO2020262157A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113143797A (zh) * 2021-04-20 2021-07-23 东晟源研究院(广州)有限公司 一种含改善雾化效果组合物的保湿化妆水及其制备方法
CN113712827B (zh) * 2021-08-20 2023-08-04 华熙生物科技股份有限公司 含硅酸盐和枯草菌脂肽钠的喷雾乳液产品及其制备方法
CN115517983A (zh) * 2022-10-25 2022-12-27 美尚(广州)化妆品股份有限公司 一种定妆喷雾及其制备方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012232970A (ja) * 2011-04-22 2012-11-29 Rohto Pharmaceutical Co Ltd 抗菌用組成物
JP2014181206A (ja) * 2013-03-19 2014-09-29 Mandom Corp 水性クレンジング化粧料
JP2016044180A (ja) * 2014-08-20 2016-04-04 ホシケミカルズ株式会社 化粧料
JP2018024639A (ja) * 2016-07-27 2018-02-15 日本精化株式会社 マンノシルエリスリトールリピッドを含有する化粧料用組成物
JP2019059679A (ja) * 2017-09-25 2019-04-18 株式会社コーセー 水性クレンジング化粧料
JP2020007304A (ja) * 2018-06-27 2020-01-16 小林製薬株式会社 皮膚洗浄用スプレー剤
JP2020007305A (ja) * 2018-06-27 2020-01-16 小林製薬株式会社 皮膚洗浄用液体組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5861241B2 (ja) * 2010-03-12 2016-02-16 日清オイリオグループ株式会社 皮膚外用組成物、化粧料、及び洗浄剤

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012232970A (ja) * 2011-04-22 2012-11-29 Rohto Pharmaceutical Co Ltd 抗菌用組成物
JP2014181206A (ja) * 2013-03-19 2014-09-29 Mandom Corp 水性クレンジング化粧料
JP2016044180A (ja) * 2014-08-20 2016-04-04 ホシケミカルズ株式会社 化粧料
JP2018024639A (ja) * 2016-07-27 2018-02-15 日本精化株式会社 マンノシルエリスリトールリピッドを含有する化粧料用組成物
JP2019059679A (ja) * 2017-09-25 2019-04-18 株式会社コーセー 水性クレンジング化粧料
JP2020007304A (ja) * 2018-06-27 2020-01-16 小林製薬株式会社 皮膚洗浄用スプレー剤
JP2020007305A (ja) * 2018-06-27 2020-01-16 小林製薬株式会社 皮膚洗浄用液体組成物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE MINTEL GNPD June 2017 (2017-06-01), "Extra Cool Shampoo ID:4882745", Database accession no. ID:4882745 *

Also Published As

Publication number Publication date
JP2021004203A (ja) 2021-01-14
CN112367965A (zh) 2021-02-12
TW202114619A (zh) 2021-04-16

Similar Documents

Publication Publication Date Title
WO2020262157A1 (ja) 皮膚洗浄用スプレー剤
JP7471780B2 (ja) 皮膚洗浄用スプレー剤
TW201404408A (zh) 裝入無氣體起泡容器之液體洗淨劑
JP7360826B2 (ja) 皮膚洗浄用液体組成物
WO2020262154A1 (ja) 皮膚洗浄料組成物
TW200530393A (en) Detergent composition
JP2024019604A (ja) 皮膚洗浄料組成物
WO2020262158A1 (ja) 皮膚洗浄用液体組成物
WO2020262151A1 (ja) 皮膚洗浄料組成物
WO2020262156A1 (ja) 皮膚洗浄用液体組成物
WO2020262155A1 (ja) 皮膚洗浄用スプレー剤
WO2020262153A1 (ja) 皮膚洗浄用液体組成物
WO2020262152A1 (ja) 皮膚洗浄用スプレー剤
JP2020002050A (ja) 皮膚洗浄料組成物
JP7505864B2 (ja) 皮膚洗浄料組成物
JP5946416B2 (ja) 皮膚洗浄用化粧料
WO2020262159A1 (ja) 皮膚清拭用組成物
WO2021124497A1 (ja) 皮膚洗浄用液体組成物
WO2021124496A1 (ja) 皮膚洗浄用スプレー剤
CN110354014A (zh) 皮肤用清洗剂组合物
JP2023184664A (ja) 皮膚洗浄料組成物
WO2021124495A1 (ja) 皮膚洗浄料組成物
JP2015054852A (ja) 皮膚洗浄剤組成物

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20831968

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20831968

Country of ref document: EP

Kind code of ref document: A1